Delivery Order SPE2DR25D2009-SPE2DR26FJ5X5
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,091.56 by the Defense Logistics Agency (DLA) on January 27, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by January 28, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. Repatha is a prescription...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $44,909.34 by the Defense Logistics Agency on January 28, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be executed from the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $6,497.25 delivery order by the Defense Logistics Agency on January 21, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 22, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 22, 2026, for Repatha 140 mg/ml SureClick auto-injectors valued at $20,648.93. This firm fixed-price delivery order is scheduled for completion by January 23, 2026, and represents a non-competitive, non-set-aside award. The products will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Repatha is a prescription medication...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,317.04 by the Defense Logistics Agency (DLA) on January 23, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pharmaceutical product. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by January 26, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,747.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The order, with an ultimate completion date of January 23, 2026, was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Cencora, Inc.'s...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $33,760.01 by the Defense Logistics Agency on January 27, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The delivery order, which carries an ultimate completion date of January 28, 2026, represents a non-competitive award issued without set-aside designation. Performance will be executed from the awardee's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- On January 21, 2026, the Defense Logistics Agency awarded a delivery order valued at $13,950.80 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside for any specific business category, represents a child contract under AmerisourceBergen's parent company Cencora, Inc. The contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ5X5Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 28, 2026, by the Defense Logistics Agency for $11,137.26 to supply Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under full and open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. This delivery order is issued under Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs globally. Repatha, a specialty medication used for cholesterol management, represents the type of critical pharmaceutical commodity delivered through this strategic contract vehicle to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 1/27/26 |